Pomalidomide (INN; marketed as Pomalyst in the US and Imnovid in the European Union and Russia) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator.

Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.

We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.

Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.

The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.

The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.

We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.

The report will conduct a comprehensive and professional analysis of the Pomalidomide market in 2024 based on the current situation, global economic impact and other aspects.

Market Segment by Product Type

1mg Tables

2mg Tables

4mg Tables

Market Segment by Product Application

Hospital

Drug Center

Clinic

Other

Finally, the report provides detailed profile and data information analysis of leading company.

Celgene

Natco Pharma

Intas Pharmaceuticals

Indiabulls Pharmaceutical

Cipla

Glenmark Pharmaceuticals

Dr Reddy's Laboratories

Qilu Pharmaceutical

Chia Tai-Tianqing

Hanson Pharm

Meidakang Huakang Pharmaceutical

Shandong Kongfu Pharmaceutical

SL PHARM

Insights and Tools:

This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.

The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.

Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.

The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.

Research Objectives

1.To define, describe and forecast the Pomalidomide market by type, application, end user and region

2.Provide enterprise external environment analysis and SWOT analysis

3.Focuses on the key global Pomalidomide manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.

4.Provide market entry strategy analysis for new players or players preparing to enter the market

5.Keep up with international market trends and analyze the impact of the important international events on major global regions

6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape

Global Pomalidomide Market Research Report 2024, Forecast to 2029

1 Market Study Overview

1.1 Study Objectives

1.2 Pomalidomide Introduce

1.3 Combined with the Analysis of Macroeconomic Indicators

1.4 Brief Description of Research methods

1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary

2.1 Pomalidomide Segment by Type

2.1.1 1mg Tables

2.1.2 2mg Tables

2.1.3 4mg Tables

2.2 Market Analysis by Application

2.2.1 Hospital

2.2.2 Drug Center

2.2.3 Clinic

2.2.4 Other

2.3 Global Pomalidomide Market Comparison by Regions (2019-2029)

2.3.1 Global Pomalidomide Market Size (2019-2029)

2.3.2 North America Pomalidomide Status and Prospect (2019-2029)

2.3.3 Europe Pomalidomide Status and Prospect (2019-2029)

2.3.4 China Pomalidomide Status and Prospect (2019-2029)

2.3.5 Japan Pomalidomide Status and Prospect (2019-2029)

2.3.6 Southeast Asia Pomalidomide Status and Prospect (2019-2029)

2.4 Basic Product Information

2.4.1 Basic Product Information & Technology Development History

2.4.2 Product Manufacturing Process

2.4.3 Interview with Major Market Participants

2.4.4 High-end Market Analysis and Forecast

2.5 Coronavirus Disease 2020 (Covid-19): Pomalidomide Industry Impact

2.5.1 Pomalidomide Business Impact Assessment - Covid-19

2.5.2 Market Trends and Pomalidomide Potential Opportunities in the COVID-19 Landscape

2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer

3.1 Global Pomalidomide Sales and Market Share by Manufacturer (2019-2024)

3.2 Global Pomalidomide Revenue and Market Share by Manufacturer (2019-2024)

3.3 Global Pomalidomide Industry Concentration Ratio (CR5 and HHI)

3.4 Top 5 Pomalidomide Manufacturer Market Share

3.5 Top 10 Pomalidomide Manufacturer Market Share

3.6 Date of Key Manufacturers Enter into Pomalidomide Market

3.7 Key Manufacturers Pomalidomide Key Manufacturers

3.8 Mergers & Acquisitions Planning

4 Analysis of Pomalidomide Industry Key Manufacturers

4.1 Celgene

4.1.1 Compan Detail

4.1.2 Celgene Pomalidomide Product Introduction, Application and Specification

4.1.3 Celgene 160 Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.1.4 Main Business Overview

4.1.5 Celgene News

4.2 Natco Pharma

4.2.1 Compan Detail

4.2.2 Natco Pharma Pomalidomide Product Introduction, Application and Specification

4.2.3 Natco Pharma Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.2.4 Main Business Overview

4.2.5 Celgene News

4.3 Intas Pharmaceuticals

4.3.1 Compan Detail

4.3.2 Intas Pharmaceuticals Pomalidomide Product Introduction, Application and Specification

4.3.3 Intas Pharmaceuticals Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.3.4 Main Business Overview

4.3.5 Intas Pharmaceuticals News

4.4 Indiabulls Pharmaceutical

4.4.1 Compan Detail

4.4.2 Indiabulls Pharmaceutical Pomalidomide Product Introduction, Application and Specification

4.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.4.4 Main Business Overview

4.4.5 Indiabulls Pharmaceutical News

4.5 Cipla

4.5.1 Compan Detail

4.5.2 Indiabulls Pharmaceutical Pomalidomide Product Introduction, Application and Specification

4.5.3 Cipla Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.5.4 Main Business Overview

4.5.5 Cipla News

4.6 Glenmark Pharmaceuticals

4.6.1 Compan Detail

4.6.2 Glenmark Pharmaceuticals Pomalidomide Product Introduction, Application and Specification

4.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.6.4 Main Business Overview

4.6.5 Glenmark Pharmaceuticals News

4.7 Dr Reddy's Laboratories

4.7.1 Compan Detail

4.7.2 Dr Reddy's Laboratories Pomalidomide Product Introduction, Application and Specification

4.7.3 Dr Reddy's Laboratories Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.7.4 Main Business Overview

4.7.4 Main Business Overview

4.8 Qilu Pharmaceutical

4.8.1 Compan Detail

4.8.2 Qilu Pharmaceutical Pomalidomide Product Introduction, Application and Specification

4.8.3 Qilu Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.8.4 Main Business Overview

4.8.5 Qilu Pharmaceutical News

4.9 Chia Tai-Tianqing

4.9.1 Compan Detail

4.9.2 Chia Tai-Tianqing Pomalidomide Product Introduction, Application and Specification

4.9.3 Chia Tai-Tianqing Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.9.4 Main Business Overview

4.9.5 Chia Tai-Tianqing News

4.10 Hanson Pharm

4.10.1 Compan Detail

4.10.2 Hanson Pharm Pomalidomide Product Introduction, Application and Specification

4.10.3 Hanson Pharm Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.10.4 Main Business Overview

4.10.5 Hanson Pharm News

4.11 Meidakang Huakang Pharmaceutical

4.11.1 Compan Detail

4.11.2 Meidakang Huakang Pharmaceutical Pomalidomide Product Introduction, Application and Specification

4.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.11.4 Main Business Overview

4.11.5 Meidakang Huakang Pharmaceutical News

4.12 Shandong Kongfu Pharmaceutical

4.12.1 Compan Detail

4.12.2 Shandong Kongfu Pharmaceutical Pomalidomide Product Introduction, Application and Specification

4.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.12.4 Main Business Overview

4.12.5 Shandong Kongfu Pharmaceutical News

4.13 SL PHARM

4.13.1 Company Details

4.13.2 SL PHARM Pomalidomide Product Introduction, Application and Specification

4.13.3 SL PHARM Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.13.4 Main Business Overview

4.13.5 SL PHARM News

5 Global Pomalidomide Market Segment by Big Type

5.1 Global Pomalidomide Revenue, Sales and Market Share by Big Type (2019-2024)

5.1.1 Global Pomalidomide Sales and Market Share by Big Type (2019-2024)

5.1.2 Global Pomalidomide Revenue and Market Share by Big Type (2019-2024)

5.2 1mg Tables Sales Growth Rate and Price

5.2.1 Global 1mg Tables Sales Growth Rate (2019-2024)

5.2.2 Global 1mg Tables Price (2019-2024)

5.3 2mg Tables Sales Growth Rate and Price

5.3.1 Global 2mg Tables Sales Growth Rate (2019-2024)

5.3.2 Global 2mg Tables Price (2019-2024)

5.4 4mg Tables Sales Growth Rate and Price

5.4.1 Global 4mg Tables Sales Growth Rate (2019-2024)

5.4.2 Global 4mg Tables Price (2019-2024)

6 Global Pomalidomide Market Segment by Big Application

6.1 Global Pomalidomide Sales Market Share by Big Application (2019-2024)

6.2 Hospital Sales Growth Rate (2019-2024)

6.3 Drug Center Sales Growth Rate (2019-2024)

6.4 Clinic Sales Growth Rate (2019-2024)

6.5 Other Sales Growth Rate (2019-2024)

7 Global Pomalidomide Forecast

7.1 Global Pomalidomide Revenue, Sales and Growth Rate (2024-2029)

7.2 Pomalidomide Market Forecast by Regions (2024-2029)

7.2.1 North America Pomalidomide Market Forecast (2024-2029)

7.2.2 Europe Pomalidomide Market Forecast (2024-2029)

7.2.3 China Pomalidomide Market Forecast (2024-2029)

7.2.4 Japan Pomalidomide Market Forecast (2024-2029)

7.2.5 Southeast Asia Pomalidomide Market Forecast (2024-2029)

7.2.6 Other Regions Pomalidomide Market Forecast (2024-2029)

7.3 Pomalidomide Market Forecast by Type (2024-2029)

7.3.1 Global Pomalidomide Sales Forecast by Type (2024-2029)

7.3.2 Global Pomalidomide Market Share Forecast by Type (2024-2029)

7.4 Pomalidomide Market Forecast by Application (2024-2029)

7.4.1 Global Pomalidomide Sales Forecast by Application (2024-2029)

7.4.2 Global Pomalidomide Market Share Forecast by Application (2024-2029)

8 Market Analysis

8.1.1 Market Overview

8.1.2 Market Opportunities

8.1.3 Market Risk

8.1.4 Market Driving Force

8.1.5 Porter's Five Forces Analysis

8.1.6 SWOT Analysis

9 Pomalidomide Related Market Analysis

9.1 Upstream Analysis

9.1.1 Macro Analysis of Upstream Markets

9.1.2 Key Players in Upstream Markets

9.1.3 Upstream Market Trend Analysis

9.1.4 Pomalidomide Manufacturing Cost Analysis

9.2 Downstream Market Analysis

9.2.1 Macro Analysis of Down Markets

9.2.2 Key Players in Down Markets

9.2.3 Downstream Market Trend Analysis

9.2.4 Sales Channel, Distributors, Traders and Dealers

10 Research Findings and Conclusion

List of Tables and Figures

Figure Product Picture Pomalidomide

Figure Market Concentration Ratio and Market Maturity Analysis of Pomalidomide

Figure Bottom-up and Top-down Approaches for This Report

Figure Part of Our External Database

Figure Part of Our External Database

Figure Key Executives Interviewed

Table Global Pomalidomide Market Size by Big Type

Figure Global Market Share of Pomalidomide by Big Type in 2023

Figure 1mg Tables Picture (2019-2024)

Figure 2mg Tables Picture (2019-2024)

Global Pomalidomide Market Size by Big Application

Table Global Pomalidomide Market Size by Application

Figure Global Pomalidomide Market Share by Big Application in 2023

Figure Hospital Picture

Figure Drug Center Picture

Figure Clinic Picture

Figure Other Picture

Table Global Pomalidomide Comparison by Regions (M USD) （2019-2029）

Figure Global Pomalidomide Market Size (Million US$) (2019-2029)

Figure North America Pomalidomide Revenue (Million US$) Growth Rate (2019-2029)

Figure Europe Pomalidomide Revenue (Million US$) Growth Rate (2019-2029)

Figure China Pomalidomide Revenue (Million US$) Growth Rate (2019-2029)

Figure Japan Pomalidomide Revenue (Million US$) Growth Rate (2019-2029)

Figure Southeast Asia Pomalidomide Revenue (Million US$) Growth Rate (2019-2029)

Table Business Impact Assessment - Covid-19

Table Market Trends and Pomalidomide Potential Opportunities in the COVID-19 Landscape

Table Measures / Proposal against Covid-19

Table Global Pomalidomide Sales by Manufacturer (2019-2024)

Figure Global Pomalidomide Sales Market Share by Manufacturer in 2023

Table Global Pomalidomide Revenue by Manufacturer (2019-2024)

Figure Global Pomalidomide Revenue Market Share by Manufacturer in 2023

Table Global Pomalidomide Manufacturers Market Concentration Ratio (CR5 and HHI)

Figure Top 5 Pomalidomide Manufacturer (Revenue) Market Share in 2023

Figure Top 10 Pomalidomide Manufacturer (Revenue) Market Share in 2023

Table Date of Key Manufacturers Enter into Pomalidomide Market

Table Key Manufacturers Pomalidomide Product Type

Table Mergers & Acquisitions Planning

Table Celgene Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Celgene

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2019-2024

Table Company One Main Business

Table Company One Recent Development

Table Natco Pharma Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Natco Pharma

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Natco Pharma Recent Development

Table Intas Pharmaceuticals Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Intas Pharmaceuticals

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Intas Pharmaceuticals Main Business

Table Intas Pharmaceuticals Recent Development

Table Indiabulls Pharmaceutical Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Indiabulls Pharmaceutical

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Indiabulls Pharmaceutical Main Business

Table Indiabulls Pharmaceutical Recent Development

Table Indiabulls Pharmaceutical Main Business

Table Indiabulls Pharmaceutical Recent Development

Table Cipla Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Cipla

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Cipla Main Business

Table Cipla Recent Development

Table Glenmark Pharmaceuticals Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Glenmark Pharmaceuticals

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Glenmark Pharmaceuticals Main Business

Table Glenmark Pharmaceuticals Recent Development

Table Dr Reddy's Laboratories Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Dr Reddy's Laboratories

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Dr Reddy's Laboratories Main Business

Table Dr Reddy's Laboratories Recent Development

Table Qilu Pharmaceutical Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Qilu Pharmaceutical

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Qilu Pharmaceutical Main Business

Table Qilu Pharmaceutical Recent Development

Table Chia Tai-Tianqing Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Chia Tai-Tianqing

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Chia Tai-Tianqing Main Business

Table Chia Tai-Tianqing Recent Development

Table Hanson Pharm Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Hanson Pharm

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Hanson Pharm Main Business

Table Hanson Pharm Recent Development

Table Meidakang Huakang Pharmaceutical Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Meidakang Huakang Pharmaceutical

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Meidakang Huakang Pharmaceutical Main Business

Table Meidakang Huakang Pharmaceutical Recent Development

Table Shandong Kongfu Pharmaceutical Company Profile

Table Pomalidomide Product Introduction, Application and Specification of Shandong Kongfu Pharmaceutical

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table Shandong Kongfu Pharmaceutical Main Business

Table Shandong Kongfu Pharmaceutical Recent Development

Table SL PHARM Company Profile

Table Pomalidomide Product Introduction, Application and Specification of SL PHARM

Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024

Table SL PHARM Main Business

Table SL PHARM Recent Development

Figure Global Pomalidomide Sales and Growth Rate (2019-2024)

Figure Global Pomalidomide Revenue and Growth Rate (2019-2024)

Table Global Pomalidomide Sales by Regions (2019-2024)

Figure Global Pomalidomide Sales Market Share by Regions in 2023

Table Global Pomalidomide Revenue by Regions (2019-2024)

Figure Global Pomalidomide Revenue Market Share by Regions in 2023

Figure North America Pomalidomide Sales and Growth Rate (2019-2024)

Figure Europe Pomalidomide Sales and Growth Rate (2019-2024)

Figure China Pomalidomide Sales and Growth Rate (2019-2024)

Figure Japan Pomalidomide Sales and Growth Rate (2019-2024)

Figure Southeast Asia Pomalidomide Sales and Growth Rate (2019-2024)

Figure Other Regions Pomalidomide Sales and Growth Rate (2019-2024)

Table Global Pomalidomide Sales by Big Type (2019-2024)

Table Global Pomalidomide Sales Market Share by Big Type (2019-2024)

Figure Global Pomalidomide Sales Market Share by Big Type in 2023

Table Global Pomalidomide Revenue by Big Type (2019-2024)

Table Global Pomalidomide Revenue Market Share by Big Type (2019-2024)

Table Global Pomalidomide Revenue Market Share by Big Type in 2023

Figure Global 1mg Tables Sales Growth Rate (2019-2024)

Figure Global 1mg Tables Price (2019-2024)

Figure Global 2mg Tables Sales Growth Rate (2019-2024)

Figure Global 2mg Tables Price (2019-2024)

Figure Global 4mg Tables Sales Growth Rate (2019-2024)

Table Global Pomalidomide Sales by Big Application (2019-2024)

Table Global Pomalidomide Sales Market Share by Big Application (2019-2024)

Figure Global Pomalidomide Sales Market Share by Big Application in 2023

Figure Global Hospital Sales Growth Rate (2019-2024)

Figure Global Drug Center Sales Growth Rate (2019-2024)

Figure Global Clinic Sales Growth Rate (2019-2024)

Figure Global Other Sales Growth Rate (2019-2024)

Figure Global Pomalidomide Sales and Growth Rate (2024-2029)

Figure Global Pomalidomide Revenue and Growth Rate (2024-2029)

Table Global Pomalidomide Sales Forecast by Regions (2024-2029)

Table Global Pomalidomide Market Share Forecast by Regions (2024-2029)

Figure North America Sales Pomalidomide Market Forecast (2024-2029)

Figure Europe Sales Pomalidomide Market Forecast (2024-2029)

Figure China Sales Pomalidomide Market Forecast (2024-2029)

Figure Japan Sales Pomalidomide Market Forecast (2024-2029)

Figure Southeast Asia Sales Pomalidomide Market Forecast (2024-2029)

Figure Other Regions Sales Pomalidomide Market Forecast (2024-2029)

Table Global Pomalidomide Sales Forecast by Type (2024-2029)

Table Global Pomalidomide Market Share Forecast by Type (2024-2029)

Table Global Pomalidomide Sales Forecast by Application (2024-2029)

Table Global Pomalidomide Market Share Forecast by Application (2024-2029)

Table Market Opportunities in Next Few Years

Table Market Risks Analysis

Table Market Drivers

Figure Porter's Five Forces Analysis

Table Macro Analysis of Upstream Markets

Table Key Players in Upstream Markets

Table Key Players of Upstream Markets

Table Key Raw Materials

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Pomalidomide

Table Macro Analysis of Down Markets

Table Key Players in Down Markets

Table Key Players of Downstream Markets

Figure Sales Channel

Figure North America Pomalidomide Sales (K Units) Growth Rate Forecast (2024-2029)

Figure North America Pomalidomide Revenue (Million US$) Growth Rate Forecast (2024-2029)

Figure Europe Pomalidomide Sales (K Units) Growth Rate Forecast (2024-2029)

Figure Europe Pomalidomide Revenue (Million US$) Growth Rate Forecast (2024-2029)

Figure Japan Pomalidomide Production (K Units) Growth Rate Forecast (2024-2029)

Figure Japan Pomalidomide Revenue (Million US$) Growth Rate Forecast (2024-2029)

Figure China Pomalidomide Production (K Units) Growth Rate Forecast (2024-2029)

Figure China Pomalidomide Revenue (Million US$) Growth Rate Forecast (2024-2029)

Figure Methodology/Research Approach

Figure Market Size Estimation

Figure Author List